<H1>Chapter DOI: 10.1208/aapsj070360<br/>Cited-By Count: 31</H1><table border="1" width="30%"><tr><td>Total References</td><td>63</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>62</td></tr><tr><td>BibStructured Count</td><td width="10%">63</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>53</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>0</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Mansour A, Watson SJ, Akil H. Opioid receptors: Past, present and future.<Emphasis Type="Italic">Trends Neurosci</Emphasis>. 1995;18:69&#8211;70.</td><td><a href=http://dx.doi.org/10.1016/0166-2236(95)93876-Y>10.1016/0166-2236(95)93876-Y</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Kieffer BL. Opioids: First lessons from knockout mice.<Emphasis Type="Italic">Trends Pharmacol Sci</Emphasis>. 1999;20:19&#8211;26.</td><td><a href=http://dx.doi.org/10.1016/S0165-6147(98)01279-6>10.1016/S0165-6147(98)01279-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Kieffer BL. Gaveriaux-Ruff C. Exploring the opioid system by gene knockout.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 2002;66:285&#8211;306.</td><td><a href=http://dx.doi.org/10.1016/S0301-0082(02)00008-4>10.1016/S0301-0082(02)00008-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Ferguson SS, Zhang J, Barak LS, Caron MG. Role of beta-arrestins in the intracellular trafficking of G-protein-coupled receptors.<Emphasis Type="Italic">Adv Pharmacol</Emphasis>. 1998;42:420&#8211;424.</td><td><a href=http://dx.doi.org/10.1016/S1054-3589(08)60778-4>10.1016/S1054-3589(08)60778-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Luttrell LM, Lefkowitz RJ. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals.<Emphasis Type="Italic">J Cell Sci</Emphasis>. 2002;115:455&#8211;465.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Perry SJ, Lefkowitz RJ. Arresting developments in heptahelical. receptor signaling and regulation.<Emphasis Type="Italic">Trends Cell Biol</Emphasis>. 2002;12:130&#8211;138.</td><td><a href=http://dx.doi.org/10.1016/S0962-8924(01)02239-5>10.1016/S0962-8924(01)02239-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Benovic JL, Kuhn H, Weyand I, Codina J, Caron MG, Lefkowitz RJ. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: Potential role of an analog of the retinal protein arrestin (48-kDa protein).<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1987;84:8879&#8211;8882.</td><td><a href=http://dx.doi.org/10.1073/pnas.84.24.8879>10.1073/pnas.84.24.8879</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. Beta-Arrestin: A protein that regulates beta-adrenergic receptor. functions.<Emphasis Type="Italic">Science</Emphasis>. 1990;248:1547&#8211;1550.</td><td><a href=http://dx.doi.org/10.1126/science.2163110>10.1126/science.2163110</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Chavkin C, McLaughlin JP, Celver JP. Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2001;60:20&#8211;25.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Connor M, Osborne PB, Christie MJ. Mu-opioid receptor desensitization: Is morphine different?.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2004;143:685&#8211;696.</td><td><a href=http://dx.doi.org/10.1038/sj.bjp.0705938>10.1038/sj.bjp.0705938</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Bohn LM, Gainetdinov RR, Caron MG. G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: Psychostimulant and opiate studies in knockout mice.<Emphasis Type="Italic">Neuromolecular Med</Emphasis>. 2004;5:41&#8211;50.</td><td><a href=http://dx.doi.org/10.1385/NMM:5:1:041>10.1385/NMM:5:1:041</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions.<Emphasis Type="Italic">Annu Rev Neurosci</Emphasis>. 2004;27:107&#8211;144.</td><td><a href=http://dx.doi.org/10.1146/annurev.neuro.27.070203.144206>10.1146/annurev.neuro.27.070203.144206</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Zhang J, Ferguson SS, Barak LS, et al. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1998;95:7157&#8211;7162.</td><td><a href=http://dx.doi.org/10.1073/pnas.95.12.7157>10.1073/pnas.95.12.7157</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2.<Emphasis Type="Italic">Science</Emphasis>. 1999;286:2495&#8211;2498.</td><td><a href=http://dx.doi.org/10.1126/science.286.5449.2495>10.1126/science.286.5449.2495</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Bohn LM, Lefkowitz RJ, Caron MG. Differential mechanisms of morphine antinociceptive tolerance revealed in beta-arrestin2 knock-out mice.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:10494&#8211;10500.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Boln LM, Gainetdinov RR, Sotnikova TD, et al. Enhanced rewarding properties of morphine, but not cocaine, in beta-arrestin2 knock-out mice.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:10265&#8211;10273.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Mu-opioid receptor desensitization by beta-arrestin2 determines morphine tolerance but not dependence.<Emphasis Type="Italic">Nature</Emphasis>. 2000;408:720&#8211;723.</td><td><a href=http://dx.doi.org/10.1038/35047086>10.1038/35047086</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Noble F, Cox BM. Differential desensitization of mu- and delta-opioid receptors in selected neural pathways following chronic morphine treatment.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1996;117:161&#8211;169.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Sim LJ, Selley DE, Dworkin SI, Childers SR. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1996;16:2684&#8211;2692.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Przewlock B, Sieja A, Starowicz K, Maj M, Bilecki W, Przewlocki R. Knockdown of spinal opioid receptors by antisense targeting beta-arrestin reduces morphine tolerance and allodynia in rat.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 2002;325:107&#8211;110.</td><td><a href=http://dx.doi.org/10.1016/S0304-3940(02)00246-X>10.1016/S0304-3940(02)00246-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Raehal KM, Walker JKL, Bohn LM. Morphine side-effects in b-arrestin-2 knockout mice.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2005;314:1195&#8211;1201.</td><td><a href=http://dx.doi.org/10.1124/jpet.105.087254>10.1124/jpet.105.087254</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Luttrell LM, Ferguson SS, Daaka Y, et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.<Emphasis Type="Italic">Science</Emphasis>. 1999;283:655&#8211;661.</td><td><a href=http://dx.doi.org/10.1126/science.283.5402.655>10.1126/science.283.5402.655</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Luttrell LM, Daaka Y, Lefkowitz RJ. Regulation of tyrosine kinase cascades by G-protein-coupled receptors.<Emphasis Type="Italic">Curr Opin Cell Biol</Emphasis>. 1999;11:177&#8211;183.</td><td><a href=http://dx.doi.org/10.1016/S0955-0674(99)80023-4>10.1016/S0955-0674(99)80023-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y. Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1999;274:1185&#8211;1188.</td><td><a href=http://dx.doi.org/10.1074/jbc.274.3.1185>10.1074/jbc.274.3.1185</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>DeFea KA, Vaughn ZD, O&#8217;Bryan EM, Nishijima D, Dery O, Bunnett NW. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2000;97:11086&#8211;11091.</td><td><a href=http://dx.doi.org/10.1073/pnas.190276697>10.1073/pnas.190276697</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Miller WE, Maudsley S, Ahn S, Khan KD, Luttrell LM, Lefkowitz RJ. beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2000;275:11312&#8211;11319.</td><td><a href=http://dx.doi.org/10.1074/jbc.275.15.11312>10.1074/jbc.275.15.11312</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Barlic J, Andrews JD, Kelvin AA, et al. Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI.<Emphasis Type="Italic">Nat Immunol</Emphasis>. 2000;1:227&#8211;233.</td><td><a href=http://dx.doi.org/10.1038/79767>10.1038/79767</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Imamura T, Huang J, Dalle S, et al. beta-Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2001;276:43663&#8211;43667.</td><td><a href=http://dx.doi.org/10.1074/jbc.M105364200>10.1074/jbc.M105364200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.<Emphasis Type="Italic">J Cell Biol</Emphasis>. 2000;148:1267&#8211;1281.</td><td><a href=http://dx.doi.org/10.1083/jcb.148.6.1267>10.1083/jcb.148.6.1267</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Luttrell LM, Roudabush FL, Choy EW, et al. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2001;98:2449&#8211;2454.</td><td><a href=http://dx.doi.org/10.1073/pnas.041604898>10.1073/pnas.041604898</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM. Beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2002;277:9429&#8211;9436.</td><td><a href=http://dx.doi.org/10.1074/jbc.M106457200>10.1074/jbc.M106457200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Tohgo A, Choy EW, Gesty-Palmer D, et al. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2003;278:6258&#8211;6267.</td><td><a href=http://dx.doi.org/10.1074/jbc.M212231200>10.1074/jbc.M212231200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>McDonald PH, Chow CW, Miller WE, et al. Beta-arrestin2: A receptor-regulated MAPK scaffold for the activation of JNK3.<Emphasis Type="Italic">Science</Emphasis>. 2000;290:1574&#8211;1577.</td><td><a href=http://dx.doi.org/10.1126/science.290.5496.1574>10.1126/science.290.5496.1574</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Wang Q, Zhao J, Brady AE, et al. Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors.<Emphasis Type="Italic">Science</Emphasis>. 2004;304:1940&#8211;1944.</td><td><a href=http://dx.doi.org/10.1126/science.1098274>10.1126/science.1098274</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.<Emphasis Type="Italic">Science</Emphasis>. 2001;294:1307&#8211;1313.</td><td><a href=http://dx.doi.org/10.1126/science.1063866>10.1126/science.1063866</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Shenoy SK, Lefkowitz RJ. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2003;278:14498&#8211;14506.</td><td><a href=http://dx.doi.org/10.1074/jbc.M209626200>10.1074/jbc.M209626200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Shenoy SK, Lefkowitz RJ. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of 7TM receptor-signalosomes.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2005;280:15315&#8211;15324.</td><td><a href=http://dx.doi.org/10.1074/jbc.M412418200>10.1074/jbc.M412418200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Cvejic S, Devi LA. Dimerization of the delta opioid receptor: Implication for a role in receptor internalization.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1997;272:26959&#8211;26964.</td><td><a href=http://dx.doi.org/10.1074/jbc.272.43.26959>10.1074/jbc.272.43.26959</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function.<Emphasis Type="Italic">Nature</Emphasis>. 1999;399:697&#8211;700.</td><td><a href=http://dx.doi.org/10.1038/21441>10.1038/21441</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2004;101:5135&#8211;5139.</td><td><a href=http://dx.doi.org/10.1073/pnas.0307601101>10.1073/pnas.0307601101</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Wang D, Sun X, Bohn LM, Sadee W. Opioid receptor homo- and hetero-dimerization in living cells by quantitative bioluminescence resonance energy transfer.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2005;67:2173&#8211;2184.</td><td><a href=http://dx.doi.org/10.1124/mol.104.010272>10.1124/mol.104.010272</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2001;98:343&#8211;348.</td><td><a href=http://dx.doi.org/10.1073/pnas.011384898>10.1073/pnas.011384898</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Pan YX, Bolan E, Pasternak GW. Dimerization of morphine and orphanin FQ/nociceptin receptors: Generation of a novel opioid receptor subtype.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2002;297:659&#8211;663.</td><td><a href=http://dx.doi.org/10.1016/S0006-291X(02)02258-1>10.1016/S0006-291X(02)02258-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Pfeiffer M, Koch T, Schroder H, et al. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2001;276:14027&#8211;14036.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, Schulz S. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2002;277:19762&#8211;19772.</td><td><a href=http://dx.doi.org/10.1074/jbc.M110373200>10.1074/jbc.M110373200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Pfeiffer M, Kirscht S, Stumm R, et al. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2003;278:51630&#8211;51637.</td><td><a href=http://dx.doi.org/10.1074/jbc.M307095200>10.1074/jbc.M307095200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Yu Y, Zhang L, Yin X, Sun H, Uhl GR, Wang JB. Mu opioid receptor phosphorylation, desensitization, and ligand efficacy.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1997;272:28869&#8211;28874.</td><td><a href=http://dx.doi.org/10.1074/jbc.272.46.28869>10.1074/jbc.272.46.28869</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ. Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2000;20:4555&#8211;4562.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Yabaluri N, Medzihradsky F. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1997;52:896&#8211;902.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Arden JR, Segredo V, Wang Z, Lameh J, Sadee W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged muopioid receptor expressed in HEK 293 cells.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1995;65:1636&#8211;1645.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1995.65041636.x>10.1046/j.1471-4159.1995.65041636.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Keith DE, Murray SR, Zaki PA, et al. Morphine activates opioid receptors without causing their rapid internalization.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1996;271:19021&#8211;19024.</td><td><a href=http://dx.doi.org/10.1074/jbc.271.46.29279>10.1074/jbc.271.46.29279</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Sternini C, Spann M, Anton B, et al. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1996;93:9241&#8211;9246.</td><td><a href=http://dx.doi.org/10.1073/pnas.93.17.9241>10.1073/pnas.93.17.9241</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Whistler JL, von Zastrow M. Morphine-activated opioid receptors elude desensitization by beta-arrestin.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1998;95:9914&#8211;9919.</td><td><a href=http://dx.doi.org/10.1073/pnas.95.17.9914>10.1073/pnas.95.17.9914</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS. Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;66:106&#8211;112.</td><td><a href=http://dx.doi.org/10.1124/mol.66.1.106>10.1124/mol.66.1.106</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Koch T, Widera A, Bartzsch K, et al. Receptor endocytosis counteracts the development of opioid tolerance.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2005;67:280&#8211;287.</td><td><a href=http://dx.doi.org/10.1124/mol.104.004994>10.1124/mol.104.004994</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Cheng ZJ, Yu QM, Wu YL, Ma L, Pei G. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1998;273:24328&#8211;24333.</td><td><a href=http://dx.doi.org/10.1074/jbc.273.38.24328>10.1074/jbc.273.38.24328</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Gurevich EV, Benovic JL, Gurevich VV. Arrestin 2 expression selectively increases during neural differentiation.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2004;91:1414&#8211;1416.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.2004.02830.x>10.1111/j.1471-4159.2004.02830.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Terwilliger RZ&#8217;, Ortiz J, Guitart X, Nestler EJ. Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1994;63:1983&#8211;1986.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1994.63051983.x>10.1046/j.1471-4159.1994.63051983.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Fan XL, Zhang JS, Zhang XQ, Yue W, Ma L. Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine.<Emphasis Type="Italic">Neuroscience</Emphasis>. 2003;117:383&#8211;389.</td><td><a href=http://dx.doi.org/10.1016/S0306-4522(02)00930-2>10.1016/S0306-4522(02)00930-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Hurle MA. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2001;77:486&#8211;492.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2001.00268.x>10.1046/j.1471-4159.2001.00268.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Diaz A, Pazos A, Florez J, Ayesta FJ, Santana V, Hurle MA. Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism.<Emphasis Type="Italic">Neuroscience</Emphasis>. 2002;112:345&#8211;353.</td><td><a href=http://dx.doi.org/10.1016/S0306-4522(02)00073-8>10.1016/S0306-4522(02)00073-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Ferrer-Alcon M, La Harpe R, Garcia-Sevilla JA. Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts.<Emphasis Type="Italic">Brain Res Mol Brain Res</Emphasis>. 2004;121:114&#8211;122.</td><td><a href=http://dx.doi.org/10.1016/j.molbrainres.2003.11.009>10.1016/j.molbrainres.2003.11.009</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Haberstock-Debic H, Wein M, Barrot M, et al. Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:4324&#8211;4332.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></table>